Comments

Biogen Stock Guidance

BIIBNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$175.74

1.640.94%

At close: Dec 12, 4:00 PM EST

$177.62

1.881.07%

Pre-Market: 8:31 AM EST

Overview News Earnings Options

Guidance

Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Biogen Stock Guidance | NASDAQ:BIIB | Benzinga

Biogen issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
10/30/2025	BIIB	Biogen	FY	2025	$14.50	$15.00	$15.70	$9.68B	$9.77B	$9.68B	Get Alert
07/31/2025	BIIB	Biogen	FY	2025	$15.50	$16.00	$14.69	—	—	—	Get Alert
05/01/2025	BIIB	Biogen	FY	2025	$14.50	$15.50	$15.20	—	—	—	Get Alert
02/12/2025	BIIB	Biogen	FY	2025	$15.25	$16.25	$16.24	—	—	—	Get Alert
10/30/2024	BIIB	Biogen	FY	2024	$16.10	$16.60	$16.19	—	—	—	Get Alert
08/01/2024	BIIB	Biogen	FY	2024	$15.75	$16.25	$15.58	—	—	—	Get Alert
04/24/2024	BIIB	Biogen	FY	2024	$15.00	$16.00	$15.46	—	—	—	Get Alert
02/13/2024	BIIB	Biogen	FY	2024	$15.00	$16.00	$15.65	—	—	—	Get Alert
11/08/2023	BIIB	Biogen	FY	2023	$14.50	$15.00	$15.29	—	—	—	Get Alert
07/25/2023	BIIB	Biogen	FY	2023	$15.00	$16.00	$15.42	—	—	—	Get Alert
04/25/2023	BIIB	Biogen	FY	2023	$15.00	$16.00	$15.48	—	—	—	Get Alert
02/15/2023	BIIB	Biogen	FY	2023	$15.00	$16.00	$15.72	—	—	—	Get Alert
10/25/2022	BIIB	Biogen	FY	2022	$16.50	$17.15	$16.49	$10.00B	$10.15B	$10.00B	Get Alert
07/20/2022	BIIB	Biogen	FY	2022	$15.25	$16.75	$15.54	$9.90B	$10.10B	$9.84B	Get Alert
05/03/2022	BIIB	Biogen	FY	2022	$14.25	$16.00	$15.44	$9.70B	$10.00B	$9.87B	Get Alert
02/03/2022	BIIB	Biogen	FY	2022	$14.25	$16.00	$18.85	$9.70B	$10.00B	$10.34B	Get Alert

FAQ

What is the most recent guidance for Biogen (BIIB)?

The most recent guidance for Biogen (BIIB) was reported on October 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $14.50 to $15.00, compared to the estimated EPS of $15.70. Additionally, Biogen forecasted revenue between $9.68B and $9.77B for the quarter.

Browse guidance and forecast on all stocks.